Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,041.28
(
0.26%
)
US TECH 100
25,608.00
(
0.44%
)
Dow Jones
48,578.72
(
0.09%
)
Brent Oil
95.10
(
0.09%
)
Bitcoin
74,966.29
(
-0.29%
)
News Focus
News Focus
Post# of 257420
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: bladerunner1717 post# 142486

Wednesday, 05/23/2012 9:27:34 PM

Wednesday, May 23, 2012 9:27:34 PM

Post# of 257420

Dr. Ron Garren says that CLDX will try to do a small, single-arm study with PFS as the primary endpoint under "accelerated approval."



Wow.

Does not the FDA clearly not consider time based endpoints in single arm studies for registrational purposes (even accelerated)?

Who is smoking what?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now